Skip to main content
OpenTrials
Completed

NCT Number: NCT01830933

Breast Cancer Risk Reduction: A Patient Doctor Intervention

The proposed research combines the scientific advances in breast cancer research with health information technology (IT) to design a personalized intervention that assesses breast cancer risk for women, disseminates important breast health information, and facilitates discussion of breast cancer risk reduction practices. Our goal is to implement a tablet-PC (personal computer) based breast cancer risk education (BreastCare) intervention in the primary care setting that estimates a woman's individual risk for breast cancer and provides her and her physician with personalized breast cancer risk information and recommendations for action.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year–74 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

San Francisco General Hospital (SFGH), San Francisco, California, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient component:
  • Women who visit the General Internal Medicine (GIM) practices at SFGH and UCSF during the study period
  • Between the ages of 40 and 74
  • Self-identify as Asian American, Spanish- and English-speaking Latinas, African American, or White
  • Have no history of breast cancer are eligible to participate.
  • Physician component: Primary care physicians currently practicing at the GIM clinics at SFGH and UCSF

Exclusion criteria

  • Patient component: Women whose physicians object to their participation in the study
  • Physician component: No exclusion criteria for physicians

Treatment and study plan

BreastCARE

Other

Physician Report. At the time of an individual participant's visit to her primary care physician and her completion of the assessment tool, her physician will receive a physician report. The physician report is designed to facilitate communication about breast cancer risk during the primary care visit and to provide tailored risk reduction recommendations.

Primary outcomes

  1. Knowledge of Breast Cancer Risk Factors

    Time frame: one week post-initial visit (approximately one week)

    Risk knowledge was assessed using a post-survey. Participants could have scored 0-100 (with 0 meaning no correct answers, and 100 is all correct answers). This outcome was measured through a survey. Breast cancer risk knowledge was based on a series of eight questions in the survey. O

  2. Percentage of Participants With Correct Perception of Risk

    Time frame: baseline, one week post-initial visit (approximately one week)

    This outcome was measured through a survey. Women were asked what they thought about their risk of getting breast cancer was compared to other women of the same age.

  3. Percentage of Participants Who Had a Discussion of Breast Cancer Risk

    Time frame: one week post-initial visit (approximately one week)

    Self-reported discussion of breast cancer risk with physicians.

  4. Percentage of Participants Who Reported Discussion of Mammography Screening

    Time frame: up to 14 months

    Self reported discussion of mammography with physician.

Sponsors and collaborators

Lead sponsor

University of California, San Francisco

Other

Collaborators

  • California Breast Cancer Research Program
  • Susan G. Komen Breast Cancer Foundation

Registry information

Acronym: BreastCARE

Important dates

Study start
2011
Primary completion
2012
Study completion
2012
First posted
Apr 12, 2013
Registry last updated
Aug 19, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.